These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16440833)

  • 1. An alternative approach to evaluation of poolability for stability studies.
    Liu JP; Tung SC; Pong YM
    J Biopharm Stat; 2006; 16(1):1-14. PubMed ID: 16440833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shelf life determination based on equivalence assessment.
    Tsong Y; Chen WJ; Lin TY; Chen CW
    J Biopharm Stat; 2003 Aug; 13(3):431-49. PubMed ID: 12921392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bracketing and matrixing designs for a two-year stability study.
    Pong A; Raghavarao D
    J Biopharm Stat; 2000 May; 10(2):217-28. PubMed ID: 10803726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance levels for stability pooling test: a simulation study.
    Chen WJ; Tsong Y
    J Biopharm Stat; 2003 Aug; 13(3):355-74. PubMed ID: 12921387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pooling batches in drug stability study by using constant-width simultaneous confidence bands.
    Liu W; Jamshidian M; Zhang Y; Bretz F; Han XL
    Stat Med; 2007 Jun; 26(14):2759-71. PubMed ID: 17133619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined statistical analyses for long-term stability data with multiple storage conditions: a simulation study.
    Almalik O; Nijhuis MB; van den Heuvel ER
    J Biopharm Stat; 2014; 24(3):493-506. PubMed ID: 24697656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCOVA approach for shelf life analysis of stability study of multiple factor designs.
    Tsong Y; Chen WJ; Chen CW
    J Biopharm Stat; 2003 Aug; 13(3):375-93. PubMed ID: 12921388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On statistical evaluation of the linearity in assay validation.
    Hsieh E; Liu JP
    J Biopharm Stat; 2008; 18(4):677-90. PubMed ID: 18607801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tests for equivalence based on odds ratio for matched-pair design.
    Liu JP; Fan HY; Ma MC
    J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian hierarchical modeling of drug stability data.
    Chen J; Zhong J; Nie L
    Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooling data for stability studies: testing the equality of batch degradation slopes.
    Ruberg SJ; Stegeman JW
    Biometrics; 1991 Sep; 47(3):1059-69. PubMed ID: 1742430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
    Liu JP; Ma MC; Wu CY; Tai JY
    Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalence tests for shelf life and average drug content in stability studies.
    Djira GD; Hothorn LA; Tsong Y
    J Biopharm Stat; 2008; 18(5):985-95. PubMed ID: 18781530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of stability variation among batches, packaging, and formulations--application of matrixing and bracketing].
    Yoshioka S; Aso Y; Kojima S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):192-4. PubMed ID: 10097539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Conference on Harmonisation: guidance on Q1D bracketing and matrixing designs for stability testing of new drug substances and products; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jan; 68(11):2339-40. PubMed ID: 12532979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of stability study designs.
    Lin TY; Chen CW
    J Biopharm Stat; 2003 Aug; 13(3):337-54. PubMed ID: 12921386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On stability designs in drug shelf-life estimation.
    Ju HL; Chow SC
    J Biopharm Stat; 1995 Jul; 5(2):201-14. PubMed ID: 7581428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robustness and power of analysis of covariance applied to data distorted from normality by floor effects: homogeneous regression slopes.
    Sullivan LM; D'Agostino RB
    Stat Med; 1996 Mar; 15(5):477-96. PubMed ID: 8668873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the performance of the ICH guidelines for shelf life estimation.
    Quinlan M; Stroup W; Schwenke J; Christopher D
    J Biopharm Stat; 2013; 23(4):881-96. PubMed ID: 23786363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.
    Sullivan LM; D'Agostino RB
    Stat Med; 2003 Apr; 22(8):1317-34. PubMed ID: 12687657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.